- Report
- September 2025
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- August 2026
- 381 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 214 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 375 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 303 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 486 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 184 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- May 2026
- 185 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- May 2026
- 120 Pages
Global
From €5337EUR$5,950USD£4,563GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- March 2026
- 100 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- November 2025
- 150 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- July 2026
- 156 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- June 2026
- 173 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- May 2026
- 149 Pages
Global
From €4261EUR$4,750USD£3,643GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more